China and the US are close to solving the accounting rules crisis that threatens to de-list 261 China companies from US exchanges. The list of affected biopharma companies includes BeiGene, Legend Bio, Zai Labs, and many more.

The Renaissance IPO Index has rallied 77.8% since that March 18th low; double the S&P 500’s performance in the same time-frame. That has led the ratio of IPOs to the S&P 500 to have gone nearly vertical and is now at new highs